Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LLY | Common Stock | Options Exercise | $0 | +4.9K | +31.08% | $0.00 | 20.7K | Feb 1, 2025 | Direct | |
transaction | LLY | Common Stock | Tax liability | -$1.76M | -2.17K | -10.47% | $811.08 | 18.5K | Feb 1, 2025 | Direct | |
holding | LLY | Common Stock | 14.7K | Feb 1, 2025 | By Anat Hakim SLAT | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LLY | Restricted Stock Unit | Options Exercise | $0 | -4.9K | -100% | $0.00 | 0 | Feb 1, 2025 | Common Stock | 4.9K | Direct | F2 |
Id | Content |
---|---|
F1 | The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein. |
F2 | Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |